Improving health outcomes for HIV-positive individuals who inject drugs along the U.S.-Mexico border
Optimizing a bio-behavioral intervention to promote viral suppression among HIV+ people who inject drugs on the U.S.-Mexico border
This study is looking for ways to help Latinx people living with HIV who use injectable drugs to better manage their health and keep the virus under control by trying out different types of support, like therapy and medication help, over the course of a year.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11258317 on NIH RePORTER |
What this research studies
This research aims to develop an effective intervention to help Latinx individuals living with HIV who inject drugs achieve and maintain viral suppression. Using a method called multiphase optimization strategy (MOST), the study will randomly assign participants to different combinations of support services, including peer support for medication-assisted treatment, behavioral therapy for depression, medication adherence programs, and navigation assistance for HIV care. Participants will undergo assessments at the start and follow-ups at 6, 9, and 12 months to evaluate the effectiveness of these interventions in achieving sustained viral suppression.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latinx individuals living with HIV who inject drugs and are seeking support for their health management.
Not a fit: Patients who do not inject drugs or are not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the health and quality of life for HIV-positive individuals who inject drugs by enhancing their ability to manage their condition.
How similar studies have performed: Previous research has shown promise in using similar intervention strategies to improve health outcomes for marginalized populations, suggesting potential for success in this approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Lechuga, Julia — University of California, San Francisco
- Study coordinator: Lechuga, Julia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.